ADCY2 Antikörper (C-Term)
Kurzübersicht für ADCY2 Antikörper (C-Term) (ABIN1491734)
Target
Alle ADCY2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Human ADCY2
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Mouse, Rat (97%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Recombinant fragment corresponding to a region within amino acids 889 and 1091 of Adenylate cyclase 2 (SwissProt Q08462). Percent identity by BLAST analysis: Human (100%), Mouse, Rat (97%).
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
-
- ADCY2 (Adenylate Cyclase 2 (Brain) (ADCY2))
-
Andere Bezeichnung
- ADCY2 / Adenylate Cyclase 2
-
Hintergrund
-
Name/Gene ID: ADCY2
Family: Adenylate cyclase
Synonyms: ADCY2, 3,5-cyclic AMP synthetase, Adenylate cyclase 2, Adenylate cyclase II, Adenylate cyclase type 2, Adenylate cyclase, type ii, Adenylyl cyclase 2, Adenylate cyclase type II, ATP pyrophosphate-lyase 2, AC2, Adenylate cyclase 2 (brain), KIAA1060, Type II adenylate cyclase, HBAC2 -
Gen-ID
- 108
-
UniProt
- Q08462
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Target
-